SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-022593
Filing Date
2022-11-07
Accepted
2022-11-07 16:06:44
Documents
13
Period of Report
2022-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fgen-20221107.htm   iXBRL 8-K 59617
2 EX-99.1 fgen-ex99_1.htm EX-99.1 381007
  Complete submission text file 0000950170-22-022593.txt   570108

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fgen-20221107_pre.xml EX-101.PRE 9453
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fgen-20221107.xsd EX-101.SCH 2469
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fgen-20221107_lab.xml EX-101.LAB 12806
7 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20221107_htm.xml XML 4509
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 221365427
SIC: 2834 Pharmaceutical Preparations